(Q33941313)

30 July 2017

1 reference

title

Promotion of a favorable gut flora in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

30 July 2017

main subject

0 references

author name string

R J Kennedy

series ordinal

1

1 reference

30 July 2017

S J Kirk

series ordinal

2

1 reference

30 July 2017

K R Gardiner

series ordinal

3

1 reference

30 July 2017

publication date

1 May 2000

1 reference

Journal of Parenteral and Enteral Nutrition

30 July 2017

published in

1 reference

30 July 2017

volume

24

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

189-195

1 reference

Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Controlled trial of antituberculous chemotherapy in Crohn's disease: a five year follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Influence of inflammatory bowel disease on intestinal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Peptococcus magnus: a significant human pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

The faecal flora of patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Antimicrobial substance from a human Lactobacillus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Double blind, placebo controlled trial of metronidazole in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Metronidazole in Crohn's disease. A double blind cross-over clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. A prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

The control and consequences of bacterial fermentation in the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Lactulose--a potential drug for the treatment of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Probiotics in man and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Protective and pathological roles of nitric oxide in endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

The interaction of bacteria with mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Effects of short chain fatty acids on gut morphology and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Immune System Stimulation by Probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Immunomodulation of human blood cells following the ingestion of lactic acid bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Antagonistic effects of lactobacilli and pediococci to control intestinal colonization by human enteropathogens in live poultry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607100024003189

10.1177/0148607100024003189

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference